XVII EDITION – Farma-Biotech Program

Participation in the XVII edition of the Farma-Biotech Program

Different Spanish biotechnology companies and research groups, including Tetraneuron, presented on Wednesday, November, 28, 2018, a total of nine advanced innovative drug development projects to representatives of 17 national and international pharmaceutical companies at a conference organized in Madrid by the program Farma-Biotech, of Farma-industria.

 

This iniciative, which was held on November 28, aims to stimulate collaboration between national and international pharmaceutical companies, Spanish biotechnology companies and research groups, around the development of new innovative medicines. The initiative designed by Farmaindustria proposes through this day that small Spanish technology companies and research groups of specialized centers, previously selected, expose, before the pharmaceutical companies interested, products in development with sufficient potential (innovative, effective, protected) that can represent an opportunity for cooperation to be explored by both parties.
“The objective is to promote collaboration between the industry and the world of biomedical research, looking for projects with real capacity to offer a high innovative potential and with reasonable expectations of achieving commercial success in the medium term”, explains Amelia Martín Uranga, responsible of the Platform of Innovative Medicines of the Farmaindustria employers.

Farma-Biotech

The Farma-Biotech cooperation program is part of the Spanish Technological Platform for Innovative Medicines, an initiative of Farmaindustria that has the support of the Ministry of Science, Innovation and Universities.

 

Visit news: Cinco días Visit news: Redacción médica Visit news: isanidad Visit news: diariofarma

 

Compartir:

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR